Results 141 to 150 of about 16,156 (260)

Senolytics and exercise: Dual modalities for rejuvenating muscle

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend The role of senolytics on the heart and skeletal muscle. Senescent cell burden increases with ageing, disuse and disease. The senolytics dasatinib+quercetin (D+Q), navitoclax and fisetin, as well as exercise, eliminate senescent cells, reducing senescent cell burden and their senescence‐associated secretory phenotype (SASP ...
Zeynep Elif Yesilyurt‐Dirican   +4 more
wiley   +1 more source

Cardiovascular Health in Women—Across the Lifespan

open access: yesClinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar   +5 more
wiley   +1 more source

Nomogram for predicting major bleeding after off-pump coronary artery bypass grafting

open access: yesJournal of Cardiothoracic Surgery
Objective The purpose of this investigation is to develop a novel nomogram for predicting major bleeding following off-pump coronary artery bypass grafting (CABG).
Jianqin Zhu   +4 more
doaj   +1 more source

Sex‐Specific Associations of Inflammatory Biomarkers With All‐Cause and Cardiovascular Mortality Across Glycaemic Status: A Prospective UK Biobank Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4728-4740, June 2026.
ABSTRACT Aims To explore sex‐specific heterogeneity in the prognostic discrimination of inflammatory markers for mortality across different glycaemic states. Methods This prospective cohort study included 450 438 participants from the UK Biobank (median follow‐up: 15.3 years), stratified by sex and glycaemic status.
Yawen Zhang   +5 more
wiley   +1 more source

Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4975-4990, June 2026.
ABSTRACT Aims To evaluate the association between semaglutide 2.4 mg and major adverse cardiovascular events (MACE) among adults with clinical atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity without diabetes in real‐world clinical practice.
Michael G. Nanna   +10 more
wiley   +1 more source

Robustness in Older Adults: A Concept Analysis Using Rodgers' Evolutionary Approach

open access: yesNursing &Health Sciences, Volume 28, Issue 2, June 2026.
ABSTRACT As the number of healthy older adults increases, robustness has emerged as an important concept to describe individual differences in adaptability and health outcomes. However, the concept remains inconsistently defined across healthcare disciplines, necessitating conceptual clarification.
Yoosun Yang, Jun‐Ah Song
wiley   +1 more source

Emergency PCI and TAVR for Acute Myocardial Infarction in Severe Aortic Stenosis Patients

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Transcatheter aortic valve replacement (TAVR) is a viable alternative for patients with symptomatic severe aortic stenosis. Acute myocardial infarction is a contraindication to TAVR. The efficacy of emergency TAVR combined with percutaneous coronary intervention for patients presenting with acute myocardial infarction, severe aortic stenosis ...
Ruiyuan Lin   +9 more
wiley   +1 more source

Progressive Rapid Atherosclerotic Plaque Formation and Early Stent re‐Stenosis in an Untreated CLL Patient; A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT A 66 year‐old male with a history of hypertension and poor follow‐up for chronic lymphocytic leukemia (CLL) experienced two episodes of non‐ST elevation myocardial infarction (NSTEMI) within a 6 month period. Initial coronary angiography showed two‐vessel disease, and percutaneous coronary intervention (PCI) was performed on the left anterior ...
Mohammad Shojae   +4 more
wiley   +1 more source

Role of thrombin in coronary artery bypass grafting [PDF]

open access: yes, 2007
Thrombin is a multifunctional protease, which has a central role in the development and progression of coronary atherosclerotic lesions and it is a possible mediator of myocardial ischemia-reperfusion injury.
Raivio, Peter
core  

Home - About - Disclaimer - Privacy